AR and prostate carcinoma: Furthermore, significant inhibition of some AR pathway-related genes in human prostate cancer cells was identified after genistein application (at 1 μM, 5 μM and 25 μM; 48 h) (Takahashi et al., 2004[126]) (Figure 1(Fig. 1)).